Open AccessImpact of Immune Checkpoint Inhibitors with or without a Combination of Tyrosine Kinase Inhibitors on Organ-Specific Efficacy and Macrovascular Invasion in Advanced Hepatocellular Carcinoma
Author(s) -
HsinYu Kuo,
NaiJung Chiang,
ChiaoHsiung Chuang,
ChiungYu Chen,
IChin Wu,
TingTsung Chang,
HongMing Tsai,
YihJyh Lin
Publication year - 2020
Publication title -
oncology research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.553
H-Index - 48
eISSN - 2296-5262
pISSN - 2296-5270
DOI - 10.1159/000505933
Subject(s) - hepatocellular carcinoma , cancer research , tyrosine kinase , medicine , immune checkpoint , tyrosine kinase inhibitor , immune system , oncology , pharmacology , immunotherapy , immunology , cancer , receptor
The tumor microenvironments of different organs often differ and thus may affect the immunotherapy response.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom